Biotech Holdings LtdShs Aktie CA0909381018
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
|
17.11.2025 17:47:18
|
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch
California-based TCG Crossover Management disclosed a new position in Liquidia Corporation (NASDAQ:LQDA) valued at approximately $38.9 million in an SEC filing on Friday.According to a filing with the Securities and Exchange Commission released on Friday, TCG Crossover Management initiated a new position in Liquidia Corporation (NASDAQ:LQDA), acquiring 1.7 million shares for an estimated $38.9 million during the third quarter. This new stake accounts for 1.9% of the fund’s reportable U.S. equity assets as of September 30, bringing the total number of reportable positions to 40.Top holdings after the filing: Continue readingWeiter zum vollständigen Artikel bei MotleyFool